Danaher Co. (NYSE:DHR) Shares Acquired by Koshinski Asset Management Inc.

Posted by Defense World Staff on Apr 6th, 2023

Koshinski Asset Management Inc. increased its stake in shares of Danaher Co. (NYSE:DHR – Get Rating) by 20.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 978 shares of the conglomerate’s stock after purchasing an additional 165 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Danaher were worth $260,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of DHR. My Personal CFO LLC acquired a new position in Danaher during the 4th quarter worth $29,000. Moisand Fitzgerald Tamayo LLC grew its stake in Danaher by 5,850.0% during the 3rd quarter. Moisand Fitzgerald Tamayo LLC now owns 119 shares of the conglomerate’s stock worth $31,000 after purchasing an additional 117 shares in the last quarter. Bellwether Advisors LLC grew its stake in Danaher by 157.7% during the 3rd quarter. Bellwether Advisors LLC now owns 134 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 82 shares in the last quarter. American National Bank grew its stake in Danaher by 31.9% during the 3rd quarter. American National Bank now owns 157 shares of the conglomerate’s stock worth $41,000 after purchasing an additional 38 shares in the last quarter. Finally, Veritas Investment Partners UK Ltd. acquired a new position in Danaher during the 3rd quarter worth $52,000. 77.26% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Down 0.5 %

Danaher stock opened at $247.70 on Thursday. The stock has a 50-day simple moving average of $252.64 and a 200-day simple moving average of $259.51. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.52 and a current ratio of 1.89. The company has a market capitalization of $180.60 billion, a P/E ratio of 25.67, a PEG ratio of 2.07 and a beta of 0.80. Danaher Co. has a fifty-two week low of $233.71 and a fifty-two week high of $303.82.

Danaher (NYSE:DHR – Get Rating) last posted its quarterly earnings data on Tuesday, January 24th. The conglomerate reported $2.87 EPS for the quarter, beating the consensus estimate of $2.46 by $0.41. The firm had revenue of $8.37 billion during the quarter, compared to the consensus estimate of $7.90 billion. Danaher had a return on equity of 17.97% and a net margin of 22.91%. The firm’s revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the business earned $2.69 EPS. Equities research analysts expect that Danaher Co. will post 10.14 earnings per share for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, March 31st will be paid a dividend of $0.27 per share. The ex-dividend date is Thursday, March 30th. This is an increase from Danaher’s previous quarterly dividend of $0.25. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio is currently 11.19%.

Insider Buying and Selling at Danaher

In other Danaher news, Director Raymond C. Stevens sold 8,410 shares of the company’s stock in a transaction that occurred on Wednesday, January 25th. The stock was sold at an average price of $264.27, for a total transaction of $2,222,510.70. Following the completion of the sale, the director now directly owns 8,394 shares of the company’s stock, valued at approximately $2,218,282.38. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.20% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently commented on DHR shares. Barclays lowered their target price on Danaher from $290.00 to $270.00 and set an “overweight” rating for the company in a research note on Tuesday. Robert W. Baird decreased their price target on Danaher from $321.00 to $309.00 in a report on Wednesday, January 25th. Credit Suisse Group downgraded Danaher from an “outperform” rating to a “neutral” rating and decreased their price target for the stock from $315.00 to $300.00 in a report on Thursday, January 5th. StockNews.com initiated coverage on Danaher in a report on Thursday, March 16th. They set a “buy” rating for the company. Finally, Cowen decreased their price target on Danaher from $340.00 to $320.00 and set an “outperform” rating for the company in a report on Wednesday, January 25th. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $308.86.

Danaher Company Profile

(Get Rating)

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Get Rating).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.